The effect of L-carnitine in the treatment of anemia
Phase 3
- Conditions
- Chronic renal Disease.Chronic kidney disease, stage 5
- Registration Number
- IRCT20180921041080N1
- Lead Sponsor
- Kurdistan University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 100
Inclusion Criteria
Patients undergoing hemodialysis
Having anemia
Hemodialysis more than one year
Age more than 20 years
Exclusion Criteria
Having infectious, hepatic, and cancer diseases
Previous use of L-carnitine supplement
Use of corticosteroids
Narcotic drugs, alcohol, and cigarette consumption
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Anemia. Timepoint: Mean serum hemoglobin, ferritin and iron levels are measured at the beginning and three months after the start of treatment. Method of measurement: Blood sampling.
- Secondary Outcome Measures
Name Time Method